Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ARMO BioSciences
ARMO BioSciences
Lilly cancer drug pipeline hit by trial setback
Biopharma Dive
Wed, 10/16/19 - 12:21 pm
Eli Lilly
pegilodecakin
immunotherapy
pancreatic cancer
ARMO BioSciences
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 05/12/18 - 01:10 pm
ARMO BioSciences
Eli Lilly
M&A
OPKO Health
Rayaldee
Arrowhead
Lilly Acquires Immuno-Oncology Asset With $1.6 Billion Purchase of ARMO BioSciences
CP Wire
Thu, 05/10/18 - 10:34 am
Eli Lilly
ARMO BioSciences
M&A
immuno-oncology
Lilly Acquires Immuno-Oncology Asset With $1.6 Billion Purchase of ARMO BioSciences
Thu, 05/10/18 - 10:19 am
Eli Lilly
ARMO BioSciences
M&A
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Forbes
Tue, 01/30/18 - 09:28 am
biotech
NASDAQ
IPOs
ARMO BioSciences
Menlo Therapeutics
Cue Biopharma
In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M
Endpoints
Tue, 01/2/18 - 07:41 pm
biotech
IPOs
PureTech
ARMO BioSciences
Menlo Therapeutics
Solid Biosciences
With $50M round, ARMO BioSciences bets on next-generation cancer drug combos
Bizjournals.com
Wed, 02/10/16 - 10:30 am
ARMO BioSciences
venture capital
Alphabet
Celgene
cancer immunotherapy